Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001023024-25-000015
Filing Date
2025-02-28
Accepted
2025-02-28 07:05:36
Documents
124
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K anip-20241231.htm   iXBRL 10-K 3101118
2 EX-19.1 exhibit191aniinsidertradin.htm EX-19.1 78446
3 EX-21 anip-20241231xexx21.htm EX-21 7844
4 EX-23.1 anip-2024x1231xexx231.htm EX-23.1 2906
5 EX-31.1 anip-20241231xexx311.htm EX-31.1 10191
6 EX-31.2 anip-20241231xexx312.htm EX-31.2 10218
7 EX-32.1 anip-20241231xexx321.htm EX-32.1 7515
13 anip-20241231_g1.jpg GRAPHIC 397690
  Complete submission text file 0001023024-25-000015.txt   17116488

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anip-20241231.xsd EX-101.SCH 101207
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anip-20241231_cal.xml EX-101.CAL 154913
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anip-20241231_def.xml EX-101.DEF 710148
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anip-20241231_lab.xml EX-101.LAB 1278850
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anip-20241231_pre.xml EX-101.PRE 992190
127 EXTRACTED XBRL INSTANCE DOCUMENT anip-20241231_htm.xml XML 2314342
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31812 | Film No.: 25682530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)